PROCEPT BioRobotics Corporation Increase (Decrease) in Derivative Liabilities
PROCEPT BioRobotics Corporation (PRCT) reported Increase (Decrease) in Derivative Liabilities of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDerivativeLiabilities · last filed 2026-02-26
- PROCEPT BioRobotics Corporation increase (decrease) in derivative liabilities for the quarter ending 2025-12-31 was $0.00.
- PROCEPT BioRobotics Corporation increase (decrease) in derivative liabilities for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- PROCEPT BioRobotics Corporation increase (decrease) in derivative liabilities for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- PROCEPT BioRobotics Corporation increase (decrease) in derivative liabilities for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- PROCEPT BioRobotics Corporation increase (decrease) in derivative liabilities for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- PROCEPT BioRobotics Corporation increase (decrease) in derivative liabilities for fiscal 2024 was $114.00K, a 6.54% increase from fiscal 2023.
- PROCEPT BioRobotics Corporation increase (decrease) in derivative liabilities for fiscal 2023 was $107.00K, a 62.19% decline from fiscal 2022.
- PROCEPT BioRobotics Corporation increase (decrease) in derivative liabilities for fiscal 2022 was $283.00K.
| Period end | Increase (Decrease) in Derivative Liabilities 3 month | Increase (Decrease) in Derivative Liabilities 6 month | Increase (Decrease) in Derivative Liabilities 9 month | Increase (Decrease) in Derivative Liabilities 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | $0.00 derived: sum of 3 quarters · filed 2026-02-26 | $0.00 10-K · filed 2026-02-26 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $0.00 derived: sum of 2 quarters · filed 2025-11-05 | $0.00 10-Q · filed 2025-11-05 | $0.00 derived: sum of 4 quarters · filed 2026-02-26 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $0.00 10-Q · filed 2025-08-07 | $0.00 derived: sum of 3 quarters · filed 2026-02-26 | $58.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-02 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | $58.00K derived: sum of 3 quarters · filed 2026-02-26 | $86.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $58.00K derived: sum of 2 quarters · filed 2026-02-26 | $86.00K derived: sum of 3 quarters · filed 2026-02-26 | $114.00K 10-K · filed 2026-02-26 |
| 2024-09-30 | $58.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $86.00K derived: sum of 2 quarters · filed 2025-11-05 | $114.00K 10-Q · filed 2025-11-05 | $141.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $28.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $56.00K 10-Q · filed 2025-08-07 | $83.00K derived: sum of 3 quarters · filed 2026-02-26 | $110.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $28.00K 10-Q · filed 2025-05-02 | $55.00K derived: sum of 2 quarters · filed 2026-02-26 | $82.00K derived: sum of 3 quarters · filed 2026-02-26 | $109.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $27.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $54.00K derived: sum of 2 quarters · filed 2026-02-26 | $81.00K derived: sum of 3 quarters · filed 2026-02-26 | $107.00K 10-K · filed 2026-02-26 |
| 2023-09-30 | $27.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-28 | $54.00K derived: sum of 2 quarters · filed 2024-10-28 | $80.00K 10-Q · filed 2024-10-28 | $250.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $27.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | $53.00K 10-Q · filed 2024-08-02 | $223.00K derived: sum of 3 quarters · filed 2025-02-27 | $262.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $26.00K 10-Q · filed 2024-05-02 | $196.00K derived: sum of 2 quarters · filed 2025-02-27 | $235.00K derived: sum of 3 quarters · filed 2025-02-27 | $272.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $170.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $209.00K derived: sum of 2 quarters · filed 2025-02-27 | $246.00K derived: sum of 3 quarters · filed 2025-02-27 | $283.00K 10-K · filed 2025-02-27 |
| 2022-09-30 | $39.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $76.00K derived: sum of 2 quarters · filed 2023-11-02 | $113.00K 10-Q · filed 2023-11-02 | |
| 2022-06-30 | $37.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-28 | $74.00K 10-Q · filed 2023-07-28 | ||
| 2022-03-31 | $37.00K 10-Q · filed 2023-05-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |